Transgene Biotek Fair Value

Average Fair Value
₹2.0
Current Market Price: ₹2.49
-19.48% Price Difference

Transgene Biotek fair value. Transgene Biotek (TRABI) average fair value is ₹2.0 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹2.49 (-19.48%), fair value range ₹1.05–₹2.96. Analyse TRABI shareholder distribution to track promoter, FII and institutional holdings.

Fair Value Analysis Export

TRABI Fair Value vs Current Price — Valuation Summary

TRABI average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. For live price and a broader fundamental view, visit Transgene Biotek stock price NSE.

Average Fair Value
₹2.0
Current Market Price
₹2.49
Price Difference
₹-0.49
Percentage Difference
-19.48%
Fair Value Range
₹1.05 - ₹2.96
Methods Used
2
Analysis based on 2 valuation methods: P/B Based Valuation, Asset-Based Valuation

P/B Based Valuation

Book Value/Share ₹1.05
Sector Avg P/B 4.13
Historical Avg P/B N/A
Average Fair Value
₹2.96

Asset-Based Valuation

Book Value/Share ₹1.05
Liquidation Value/Share ₹13.26
Fair Value
₹1.05

TRABI Fair Value Analysis — Data Sources & Coverage

Transgene Biotek financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year.

Methods Used
2
Data Year
2026
Sector
Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

Data Currency: Financial data is from the current year (2026).

TRABI vs Healthcare Sector Peers — P/E, P/B & Market Cap

Transgene Biotek P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Emcure Pharmaceuticals EMCURE 40.6 8.3 ₹44,381
Modern Diagnostic & Rese… MDRC - 1.42 ₹83
Pharmaids Pharmaceuticals PHARMAID -28.7 2.2 ₹100
Glen Industries GLEN 15.7 1.97 ₹250
Broach Lifecare Hospital BROACH 90.7 0.82 ₹8

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.